Back to the main directory
Press Release
- EXL named a Leader in 2025 Gartner® Magic Quadrant™ for Finance and Accounting Business Process Outsourcing by GlobeNewsWire
- Change in the holding of WithSecure Corporation’s own shares by GlobeNewsWire
- The Southern Banc Company, Inc. Announces Third Quarter Earnings by GlobeNewsWire
- Karolinska Developments årsstämma 2025 by GlobeNewsWire
- ConnectM Completes Acquisition of Cambridge Energy Resources, Strengthening Foothold in India by GlobeNewsWire
- Sogeclair: Droits de vote au 30/04/2025 by GlobeNewsWire
- Using Machine Learning, Freddie Mac Announces Automated Underwriting That Can Save Mortgage Originators Up To $1,500 Per Loan by GlobeNewsWire
- TOUAX : Progression du niveau d’activité au 1er trimestre 2025 by GlobeNewsWire
- ARGAN achève la réhabilitation et l’extension du hub de messagerie de GEODIS à Toulouse by GlobeNewsWire
- Assemblée Générale Mixte de Transgene du 15 mai 2025 by GlobeNewsWire
- CREDIT AGRICOLE SA : Crédit Agricole Leasing & Factoring finalise l’acquisition du groupe allemand Merca Leasing by GlobeNewsWire
- Purchase of Own Securities and Total Voting Rights by GlobeNewsWire
- LACROIX annonce son projet de sortie de l’Amérique du Nord d’ici fin 2025, en vue d’un recentrage sur ses activités les plus solides et à fort potentiel. Au 1 er trimestre 2025, un chiffre d’affaires en repli de 10,4% à périmètre constant. by GlobeNewsWire
- Worldline : Modalités de mise à disposition des documents préparatoires à l'Assemblée Générale Mixte du 5 juin 2025 by GlobeNewsWire
- Solutions30 annonce la nomination de trois nouveaux directeurs généraux pour la France, l'Allemagne et la Belgique. by GlobeNewsWire
- Vallourec : by GlobeNewsWire
- Nexans Mixed Shareholders’ Meeting of May 15th, 2025 by GlobeNewsWire
- Groupe IT Link : + 1,8% de croissance du chiffre d’affaires au T1 2025 by GlobeNewsWire
- vTv Therapeutics Announces Reinitiation of Screening in CATT1 Phase 3 Trial Evaluating Potential First-in-Class Liver-Selective Glucokinase Activator Cadisegliatin for Type 1 Diabetes by GlobeNewsWire
- Transaction in Own Shares by GlobeNewsWire
- Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris by GlobeNewsWire
- AGRIForce Growing Systems Ltd. to Attend Bitcoin 2025 in Las Vegas by GlobeNewsWire
- Marksmen Energy Inc. Provides Update on the Filing of its 2024 Annual Financial Statements by GlobeNewsWire
- Sanofi: Informations relatives au nombre de droits de vote et d'actions - Avril 2025 by GlobeNewsWire
- Air France-KLM annonce le succès de son émission d’obligations hybrides by GlobeNewsWire